Invitation to presentation of BioArctic’s third quarter report for July – September 2024 on November 14 at 9.30 a.m. CET
STOCKHOLM, Nov. 6, 2024 /PRNewswire/ — BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) will publish the company’s third quarter report for July – September 2024 on Thursday, November 14, 2024, at 08:00 a.m. CET. In conjunction to the report, BioArctic invites investors, analysts,
Hanmi Unveils Novel Obesity Drug ‘HM17321’ : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss
Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: Enhanced Fat Loss with Lean Mass IncreaseImproved Weight Loss and Muscle Preservation with HM15275 Combinati
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that multiple studies
Crowne Plaza Phu Quoc Starbay Invites Travelers to Create Memorable Journey on One of the World’s Most Beautiful Islands
PHU QUOC, Vietnam, Nov. 6, 2024 /PRNewswire/ — Crowne Plaza Phu Quoc Starbay warmly welcomes travelers from Greater China for a perfect autumn and winter retreat. With Cantonese and Mandarin-speaking staff and China Ready certification, guests will feel right at home. There is no better time t
Xinhua Silk Road: Yangtze River culture and art season wraps up in C. China Hubei Yichang
BEIJING, Nov. 6, 2024 /PRNewswire/ — The Yangtze River Cultural and Artistic Season officially wrapped up on Monday with closing ceremony held in Yichang City, central China’s Hubei Province. Themed on inheriting Yangtze River cultural heritage and writing a glorious chapter in the new
ASEAN FinTech funding grew more than 10-fold in past decade, GenAI and Quantum Computing to power new era: FinTech in ASEAN 2024 report
Optimism in ASEAN’s FinTech scene as Singapore and Thailand draw top funding this year. SINGAPORE, Nov. 6, 2024 /PRNewswire/ — Funding for Financial Technology (FinTech) in ASEAN has surged more than 10 times since 2015[1], growing at an exponential rate compared to global FinTech fund
AMPCO METAL Acquires Schmelzmetall Group to Expand Capabilities and Enhance Customer Offerings
MARLY, Switzerland, Nov. 6, 2024 /PRNewswire/ — AMPCO METAL, a global leader in copper-based alloys, is pleased to announce its acquisition of Switzerland-based Schmelzmetall Group, a renowned producer of high-performance copper alloys. This strategic acquisition strengthens AMPCO METAL̵
DMEGC Solar Achieves First Carbon Neutral Factory, 100% Green Energy Production for Three Factories
DONGYANG, China, Nov. 6, 2024 /PRNewswire/ — DMEGC Solar Lianyungang Factory has just obtained the Certificate of ISO 14068 Organizational Carbon Neutrality Achievement Verification Statement, which is the first such certificate issued by TÜV SÜD in the photovoltaic industry. On the same day
COOFANDY Fulfills Your Black Friday’s Wishlist
NEW YORK, Nov. 6, 2024 /PRNewswire/ — As the holiday season approaches, a festive atmosphere fills the air, inspiring individuals to prepare thoughtful gifts for loved ones as a gesture of love and gratitude. In anticipation of the upcoming Black Friday shopping season, the modern men’s
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
NANJING, China, Nov. 6, 2024 /PRNewswire/ — On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as “Leads Biolabs”) announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D and CD3 which is independently developed by Leads Bi
